|
|
|
ALTERNATIVES FOR HEALTH |
|
|
Robert Keller MD, MS, FACP, has been named as one of the world’s
2,000 Outstanding Scientists of the 21st Century, and has served on
the scientific review panels for the National Institutes of Health
and the VA.
Dr. Keller has served on the faculties of the Mayo
Graduate School of Medicine, the University of Wisconsin and the Medical College
of Wisconsin (Marquette Univ.) He has published more than 100 original articles
in various scientific and medical journals and has been awarded several patents.
Dr Keller was elected to The Board of Governors of the American Academy of HIV
medicine, and serves on the Scientific Advisory Board of several Biotech
companies. The Consumers’ Research Council has named Dr. Keller one of America’s
“Top Physicians in 2003, 2004 and 2005 in the fields of Internal Medicine,
Immunology and Hematology. Dr. Keller continues his medical practice and
research activities at his clinic and laboratory in Florida and is Chairman of
the Board and Chief Scientific Officer of Phoenix Biosciences, Inc.
|
|
EDUCATION AND TRAINING |
|
1966 |
Bachelor of
Arts in Biology Master of Science in Biology Fordham University,
Bronx, New York |
| 1966 |
Bachelor of
Arts in Biology Master of Science in Biology Fordham University,
Bronx, New York |
| 1970 |
Doctor of
Medicine (MD) with honors Temple University, Philadelphia,
Pennsylvania |
| 1970-1974 |
Internship,
Resident and Senior Resident University of Rochester, Rochester, New
York |
| 1974-1976 |
Fellow and
Senior Fellow Department of Immunology Mayo Clinic, Rochester,
Minnesota |
| 1976 |
Master of
Science in Immunology Mayo Graduate School of Medicine Rochester,
Minnesota |
|
|
|
PROFESSIONAL AND FACULTY POSITIONS |
| 2006 |
Founder, CSO
and Director of Medicine KBK Institute of Advanced Medicine
Hollywood, Florida |
| 2001 |
Founder,
Chairman, CEO & CSO Phoenix BioSciences which has developed a new
first in class and first in man viral-host interaction inhibitor for
HIV / AIDS |
| 1999 |
Founder,
Chairmain,CEO and CSO Vitimmune, Inc Hollywood, Florida
|
| 1998 |
Voluntary
Adjunct Professor Miller School of Medicine, University of Miami
Miami, Florida |
| 1996 |
Chairman and
CEO Immune Balance Technologies Hollywood, Florida |
| 1994-2006 |
Director of
Medicine & Research BIODORON Medical Center Hollywood, Florida
|
| 1994-1995 |
Consultant in
Immunology and Hematology Health Professionals, Inc and Center for
Special Immunology |
| 1992-1995 |
Director
Immune Reconstitution Program Center for Special Immunology
|
| 1992-1995 |
Medical
Director Center for Special Immunology Miami Beach, Florida
|
| 1987-1996 |
President and
Medical Director The Wilson Bode Center Fort Lauderdale, Florida
|
| 1986-1987 |
Associate
Director of Research and Development Coulter Immunology Coulter
Electronics, Inc., Hialeah, Florida |
| 1982-1986 |
Medical
Director Wilson Bode Center for Hematology and Immunology Research
Milwaukee, Wisconsin |
| 1982-1986 |
Clinical
Professor Department of Health Sciences (Hematology, Immunology,
Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin
|
| 1982-1986 |
Associate
Professor Departments of Medicine and Biophysics Medical College of
Wisconsin Milwaukee, Wisconsin |
| 1982-1986 |
Clinical
Investigator and Staff Physician Zablocki VAMC Milwaukee, Wisconsin
|
| 1980-1982 |
Director of
Immunology Midwest Children's Cancer Center (Immunology, Flow
Cytometry, Transplantation) Chief of Immunology Milwaukee Children's
Hospital Milwaukee, Wisconsin |
| 1980-1982 |
Associate
Professor Department of Pediatrics (Hematology/Oncology, Immunology)
Medical College of Wisconsin Milwaukee, Wisconsin |
| 1979-1982 |
Clinical
Associate Professor Department of Health Sciences (Hematology,
Immunology, Flow Cytometry) University of Wisconsin Milwaukee,
Wisconsin |
| 1978-1980 |
Research
Associate and Staff Physician Research Service Zablocki VAMC
Milwaukee, Wisconsin |
| 1977-1980 |
Assistant
Professor Department of Medicine (Hematology/Oncology) Medical
College of Wisconsin Milwaukee, Wisconsin |
| 1977 |
Consultant
And Assistant Professor Department of Immunology Mayo Medical School
Dept. of Medicine University of Minnesota |
| 1974-1977 |
Fellow and
Senior Research Fellow in Immunology Mayo Clinic Foundation Mayo
Graduate School of Medicine Rochester, Minnesota |
|
|
|
HOSPITAL STAFF APPOINTMENTS |
| 1976-1977
|
Mayo Clinic,
Rochester, Minnesota |
| 1977-1986
|
Zablocki VAMC,
Milwaukee, Wisconsin |
| 1977-1986
|
Milwaukee
County Medical Complex, Milwaukee, Wisconsin |
| 1992-1997
|
Mount Sinai
Medical Center, Miami Beach, Florida |
| 1992-1999
|
Cleveland
Clinic Hospital, Fort Lauderdale, Florida |
| 1992-1999
|
Miami Heart
Institute, Miami Beach, Florida |
| 1997-1999
|
Palmetto
General Hospital, Hialeah, Florida |
| 1997- 2005
|
South Shore
Hospital, Miami Beach, Florida |
| 1997- 2005
|
Memorial
Medical Center, Hollywood, Florida |
| 1992-
|
Broward
General Medical Center, Fort Lauderdale, Florida |
| 1997-
|
Hollywood
Medical Center, Hollywood, Florida |
|
|
|
FELLOWSHIPS AND AWARDS |
| 1967-1969
|
Health
Professions Scholarship
Temple University School of Medicine |
| 1974-1975
|
Mayo
Foundation Research Fellowship
Mayo Graduate School of Medicine |
| 1975-1978
|
National
Arthritis Foundation Fellowship |
| 1978-1981
|
VA Career
Development Award, Research Associate |
| 1983-1986
|
VA Career
Development Award, Clinical Investigator |
|
|
|
GRANT SUPPORT DURING ACADEMIC TENURE |
|
1978-1980 |
Alpha-fetoprotein Immunoregulation in a Model of Murine Lymphoma
Veterans Administration Research Principal Investigator
|
$210,000
|
| 1981-1986
|
Immunoregulatory Dysfunction in Non-Hodgkin's Lymphoma NIH, NCI
Principal Investigator |
$430,000
|
| 1982-1986
|
Immunologic
Studies of Environmental Lung Disease NIH (NIAID) Co-Principal
Investigator |
$525,000
|
| 1983-1986
|
VA Career
Development Award Clinical Investigator |
$240,000
|
| 1984-1986
|
Clinical
Applications of Laser Flow Cytometry Principal Investigator NIH (RR
Shared Equipment Program) |
$105,609
|
| 1984-1987
|
Immunoregulatory Dysfunction Principal Investigator VA
|
$245,000
|
| 1985-1986
|
Monoclonal
Antibodies in the Detection of Cervical Carcinoma Co-Principal
Investigator Hillman Foundation |
$85,000
|
| 1986-1987
|
Isoprinosine
Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC
Principal Investigator of FDA IND Newport Foundation
|
$125,000
|
| 1986-1987
|
Isoprinosine
Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC
Principal Investigator of FDA IND Newport Foundation
|
$125,000
|
|
|
|
HONORS |
|
1970 |
Alpha Omega
Alpha Temple University, School of Medicine |
| 1970
|
Medical
Degree with honors Temple University, School of Medicine
|
| 1979
|
Superior
Performance Award in Research Veterans Administration
|
| 1980
|
Fellow,
American College of Physicians |
| 1991
|
Who's Who in
Science and Technology |
| 1994
|
Who's Who in
the World |
| 1996
|
Who's Who in
Medicine and Science |
| 1998
|
HIV Medical
Professional of the Year PWAC, Broward County, Florida
|
| 1999
|
Humanitarian
of the Year National Hemophilia Foundation |
| 2001
|
2000
Outstanding Scientists of the 21st Century |
| 2002
|
1000 Great
Americans of the 21st Century |
| 2003
|
America's Top
Physicians in Internal Medicine, Immunology and Hematology
|
| 2004
|
Elected to
Board of Governors |
|
|
|
ACADEMY OF HIV MEDICINE OF THE STATE OF FLORIDA |
| 2004
|
AMA
Physicians Recognition Award |
| 2005
|
Greatest
Scholars of the Twenty First Century |
| 2006
|
Health
Professional of the Year Invited Lectureships: |
| 1977
|
Second
Fogarty International Conference on Neonatal Liver Disease
Baltimore, Maryland |
| 1977
|
International
Conference on the Diagnosis and Prevention of Neural Tube Defects
Los Angeles, California |
| 1977
|
Second
International Conference on Diagnostic Immunology Henniker, New
Hampshire |
| 1979
|
Radio
immunochemical Detection of Cancer Albuquerque, New Mexico
|
| 1980
|
Visiting
Professor of Hematology University of Mississippi Jackson,
Mississippi |
| 1981
|
Visiting
Professor of Hematology University of California Irvine, California
|
| 1981
|
Third
International Conference on Diagnostic Immunology, Section Chair
|
| 1982
|
Visiting
Professor of Pathology University of Texas Medical Branch Galveston,
Texas |
| 1983
|
Visiting
Professor of Medicine Wilfred Hall Air Force Research Center
Galveston, Texas |
| 1984
|
Visiting
Professor Max Plank Institute for Biochemie Munich, Germany
|
| 2005
|
Visiting
Professor of Immunology and Pharmacology Peking Union Medical School
(University of Beijing) Beijing, China |
|
|
|
EDITORIAL BOARDS |
| 1986-1990
|
Diagnostic
Immunology |
| 1984-1986
|
Journal of
Leukocyte Biology |
| 2005
|
Interventions
in Aging |
|
|
|
REVIEWER |
| 1990-Present
|
Journal of
Immunology |
| 2005
|
Interventions
in Aging |
|
|
|
Consultant ships: |
|
Coulter Epics |
|
Coulter Immunology |
|
Corning Scientific |
|
National Aeronautics and Space Administration (NASA)
|
|
Abbott HIV Advisory Board |
|
Baxter Advisory Board for Hemophilia |
|
Baxter Advisory Board for Hemophilia Inhibitor Patients
|
|
Consultant in Cancer Therapy, PRSS-J, Tokyo, 2005 |
|
Medical Advisory Council, American Federation of Hemophilia, 2002
|
|
|
|
Board of Director Appointments: |
| 2006
|
Member
American Academy of HIV Medicine |
| 2006
|
Member
Biosource Therapeutics |
| 2001
|
Chairman,
Phoenix Bioscience |
| 1999
|
Chairman,
VitImmune |
| 1996
|
Chairman, IBT
|
|
|
|
Scientific Advisory Boards: |
| 2006
|
Cytodyn Inc
|
| 2006
|
Acthelon
Medical |
| 2006
|
Bioscource
Therapeutics |
|
|
|
Certifications: |
|
National Board of Medical Examiners, 1971 and 1990 |
|
American Board of Internal Medicine, 1974 |
|
American Academy of HIV Medicine, 2001 |
|
American Academy of Anti Aging Medicine 2006 |
|
|
|
Current Medical Licensure: |
| New York
|
#112195
|
| Wisconsin
|
#19121
|
| Florida
|
#58991
|
|
|
|
Certification: |
| ACLS
|
1990
|
| ATLS
|
1990
|
|
|
|
Professional Societies: |
|
Alpha Omega Alpha |
|
American Association for the Advancement of Science |
|
American Association of Immunologists |
|
American College of Physicians |
|
American Federation of Clinical Research |
|
American Society of Clinical Pathology |
|
American Society of Hematology |
|
International Society of Hematology |
|
International Society of Hematopathology |
|
International Immunocompromised Host Society |
|
International Society of Analytical Cytology |
|
Clinical Cytometry Society |
|
New York Academy of Sciences |
|
Clinical Immunology Society |
|
National Organization for Rare Disorders |
|
American Academy of Anti Aging Medicine |
|
|
|
Teaching Experience: |
| 1978-1980
|
Survey in
Basic and Clinical Immunology Department of Medicine Medical College
of Wisconsin |
| 1980-1983
|
Principles of
Laser Flow Cytometry Department of Health Sciences University of
Wisconsin |
| 1981
|
Special
Topics in Immunology Immunoregulation in Cancer Department of
Biology Marquette University |
| 1983-1986
|
Co-Director
Flow Cytometry Program University of Wisconsin Introduction to Flow
Cytometric Analysis Principles of Image and Laser Cytometry
Hybridomas and Monoclonal Antibodies Laboratory Evaluation of
Immunoregulation Clinical Immunophenotyping and DNA Analysis
Advanced Cytometry Advanced Cytometric Techniques |
|
|
|
Invited Professional Lectures: |
1979 - Dr. Keller has been the invited speaker at more than 2500
state, regional, National, and international, medical and scientific
seminars and workshops In the fields of:
AIDS and Immunoregulation
Clinical Immunology
Chronic Fatigue Syndrome and Fibromyalgia
Autoimmune Disease and Control of Aberrant Immune Response
Nutrition and the Immune Response
Hormones and the Immune Response
Hepatitis C
Hemophilia
Protecting the Immune System Before, During, and After Cancer
Therapy.
Age Management
|
| 2000-2002
|
Host of
Today's Health, WAXY 790 and Web streamed at Vitimmune.com and
RobKellermd.org |
| 2005-2006
|
Host of Voice
America Web Based Interactive Radio Show, The Path to Wellness and
Youth |
|
|
|
Committee Service: |
| 1985-1986
|
Veterans
Administration Development Research and Committee Clement J.
Zablocki |
|
VAMC |
| 1986-1989
|
VA Oncology
Merit Review Board |
| 1984-1986
|
International
Society For Analytical Cytology: Research and Development
|
| 1983-1986
|
Controls &
Standards University of Wisconsin: Co Chair Flow Cytometry
|
| 1983-1986
|
National
Institutes of Health: Special Immunology Review Council Study
Section |
| 1980-1982
|
Medical
College of Wisconsin Faculty Welfare Committee |
| 1980-1982
|
Animal Care
Committee |
| 1982-1986
|
Flow
Cytometry Protocol Committee |
| 1992
|
Cancer
Committee for Hollywood Medical Center |
| 1998
|
Committee of
Ten Thousand Medical Advisory Board |
| 1996
|
National
Hemophilia Federation: Medical Advisory Committee |
| 1994
|
National
Hemophilia Foundation- Florida Chapter Medical Advisory Committee
|
| 1994-1997
|
Mount Sinal
Medical Center Cancer Committee |
| 2001
|
Hollywood
Medical Center Cancer Committee |
| 2005
|
Underwriting
Committee ProAssurance Malpractice |
| 2005
|
AAHIVM
Standards of Practice Committee |
|
|
|
Statement of Research Interest: |
|
HIV: Dissection of the immune perturbations Associated with HIV
infection including therapy with experimental immunomodulary agents.
|
|
Dissection of the immune perturbations Associated with hemophiliac
complication and therapeutic intervention using experimental
immunoregulatory agents. |
|
Creation and utilization of unique `designer` monoclonal antibodies
for the diagnosis, monitoring, imaging and therapy of human
hematologic and solid tumor malignancies. |
|
Immune response and immunoregulation: dissection of the basic human
immune response and the roles of cytokines and other regulatory
molecules and the demonstration and characterization of aberrant
responses in neoplastic and immunologic disease. |
|
Nutritional/ Hormonal Supplementation in Age Management and
Immunologic Disease |
|
|
|
Patents Issued: |
|
R.H. Keller and Dr. X. Wen: Allerg-ease (Patent Number 6,180,106)
(2000) |
|
R.H. Keller, D.W. Kirchenbaum: ALL-Immune (Patent Number 6,262,019)
(2002) |
|
R.H. Keller, PBS 119 a novel treatment for chronic viral infections
(Patent Number 6,734,192) (2004) |
|
|
|
Patents Pending: |
|
Keller R.H. A novel treatment For Viral Infections (CIP) 2005
|
|
Keller RH: An improved method for glutathione production in mammals
2007 |
|
Keller RH: A nutritional formula to promote weight loss in mammals
|
|
Keller RH: A novel treatment for neurodegenerative diseases
|
|
Keller RH: A nutritional formula to improve short term memory
function |
|
|
|
Books: |
|
Keller, R.H. After Thirty, Some Maintenance Is Required-A Practical
Guide to Age Management |
|
|
|
Book Chapters: |
|
Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein: A Potential
Regulator of Immune Function. In Diseases of the Liver and Biliary
Tract. Javitts, N.NIH, Bethesda, Maryland, pp. 119-134, 1977.
|
|
Keller, R.H., Calvinico, N.J., Fink, J.N., and Stevens, J.O.:
Immunobiologic Aspects of Primate Hypersensitivity Pneumonitis. In
Environmental Toxicology. Dungworth, D.L. (Ed), Academic Press, New
York, pp.383-395, 1981. |
|
Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: The
Immunobiology of Human Non-Hodgkin's' Lymphomas. In Clinical
Cellular Immunology. Ludered, A. (ed). Humana Press, New York, pp.
213-246, 1982. |
|
Patrick, C.W., Keller, R.H., and Horan, P.K.: Flow Cytometry, Cell
Sorting and Hybridomas. American Society Clinical Pathology Press.
St. Louis, MO, pp. 1-182, 1982. |
|
Patrick, C.W., Parker, J., Keller, R.H., and Horan, P.K.: The
Clinical Utility of Monoclonal Antibodies and Immunophenotyping. In
Flow Cytometry and Cell Sorting in Hematologic Disease. American
Society of American Pathologists Press. Chicago, IL pp. 1-191.
|
|
Calvinico, N.J., Fink, J.N., and Keller, R.H.: Hypersensitivity
Pneumonitis. In The Immunology of the Lung. Bienenstock, J. (Ed),
Academic Press, New York pp 365-366, 1984 |
|
Keller, R.H., Milson, T.J., Janicek, K.M., Patrick, L.C., Sohnle,
P., and Patrick, C.W.: Clinical Utilization of the Technicon H-6000
Flow Cytochemical Flow System in Allergy Testing. In Proceedings of
the 4th International Technicon Hematology Colloquium. Simson, E. (ed)
Academic Press, New York, pp 179- 188, 1984. |
|
Patrick, C.W., Horan, P.K, and Keller, R.H.: Immunophenotypic and
Functional Analysis Using Laser Flow Cytometry: Clinical Utility.
American Society of Clinical Pathology Press, Chicago, IL, 1985, pp.
1-168. |
|
Patrick, C.W. and Keller, R.H.: Lymphocytes: Biochemistry,
Physiology, Function and Morphology. In Principles of Hematology:
Clinical and Laboratory Practice. R.L. Bick, (Ed) C.V. Mosby, St.
Louis, MO in press. |
|
Patrick, C.W. and Keller, R.H.: The Emerging Role of Laser Flow
Cytometry and Monoclonal Antibodies in Clinical Medicine. In:
Principles of Hematology: Clinical Laboratory Practice. R.L. Bick
(Ed) C.V. Mosby, St. Louis, MO, in press. |
|
Keller, R.H. and Patrick, C.W.: Characterization of the Human
Myeloid Series by Monoclonal Antibodies. In Monoclonal Antibodies in
Laboratory Medicine. Swartz, M. (Ed) Academic Press, New York, in
press. |
|
Patrick, C.W., McFadden, P.W., and Keller, R.H.: Immunophenotypic
Analysis of Human Bone Marrow Employing Monoclonal Antibodies and
Laser Flow Cytometry. In Proceedings of the Second International
Conference on Technological Advances in Laboratory Hematology. Howen,
B. (ed),Academic Press, 1985. |
|
Keller, R.H., Janicek, K.M., and Patrick, C.W.: The Clinical
Significance of Laser Flow Cytometry DNA Analysis. In Proceedings of
the Second International Conference on Technological Advances in
Laboratory Hematology. Howen, B. (Ed) Academic Press, New York,
1985. |
|
Keller, R.H., Van Riel, F., Maislis, J., Lane, J.T., Reiter, W.M.,
Klimas, N.G, Fletcher, M.A.: Association of Histocompatability Class
II Antigens wit the Chronic Fatigue Immune Dysfunction Syndrome. In
Clinical Infectious Disease. University of Chicago, Chicago, IL,
1994:18 (Supp 1): S154-6. |
|
Antioxidants and the skin, A Paradigm for aging. Keller, R.H and E
Arrayove (in press) 2004. glutathione in Aging and Immunologic
Disease. Loss of Gastrointestinal During Aging and Immunologic
Disease Both Ed R. Wallace and Mechanisms of Aging Dove Press N Z,
2006 |
|
Original Research Contributions and Invited Reviews: Keller, R.H.
and Tomasi, T.B.: Alpha-fetoprotein, E-Rosette Formation and Tumor
Cell Growth. N Engl J Med 293(24): 1265-1266, 1975. |
|
Tomasi, T.B., Dattwyler, R., Murgita, R. and Keller, R.H.:
Immunosuppression By Alpha-fetoprotein. Trans Am Assoc Phys.
88:293-298, 1976. |
|
Geubel, A.P., Keller, R.H., Summerkill, W.H.J., Dickson, E.R.,
Tomasi, T.B. and Shorter, R.G.: Lymphocyte Cytotoxicity and
Inhibition Studied with Autologous Liver Cells: Observation in
Chronic Acute Liver Disease and the Primary Biliary Cirrhosis
Syndrome. Gasterenterol. 71:450-459, 1976. |
|
Keller, R.H. and Clavanico, N.J., and Tomasi, T.B.:
Immunosuppressive Properties of AFP: Role of Estrogens. In Onco
Developmental Gene Expression. Fichman, W.H. and Sell, S. (eds)
Academic Press, New York, p.278, 1976. |
|
Keller, R.H. and Tomasi, T.B.: Synthesis of Alpha-fetoprotein by
Murine Lymphoid Cells in Allogenic Reactions. J Exp Med 143:1120,
1976. |
|
Banks, P., Keller, R.H., Li, V.Y. and White, E.B.: Malignant
Lymphomas of Plasmablastic Identity: A Neoplasm with Both "Immunoblastic"
and Plasma Cell Features. Am J Med 64:609-610, 1978.
|
|
Keller, R.H., Atwater, J.S., Martin, R.S. and Tomasi, T.B.: Ataxia
Telangiectasia, Immunosuppression and AFP: Is There a Relationship?
In Prevention of Neural- Tube Defects. Crandall, B. (ed) Academic
Press, New York, pp.27-40, 1978. |
|
Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde,
J., Brodky, F., Lynch, J., Rankin, L. and Malony, K.:
Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) in
Cancer-Prone Families: Communicable Implications. In Proceeding of
the Third Annual Symposium on the Detection and Prevention of
Cancer. Part I (2), 1987. |
|
Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.:
Alpha-fetoprotein in Human Lymphoproliferative Disease. J Lab Clin
Immunol, 2:93-98, 1979. |
|
Kaplan, H.J., Meredith, T.A., Aeberg, T.M. and Keller, R.H.:
Intraocular Reticulum Cell Sarcoma (Histiocytic Lymphoma) in
Richter's Syndrome: A Neoplasm of the Immune System. Arch Opthal
98:707-710, 1980. |
|
Keller, R.H., Blake, B.G., Lyman, S. and Siebenlist, R.:
ImmunoregulatoryAbnormalities in Chronic Lymphocytic Leukemia. J Lab
Clin Immunol 6:201-208, 1981. |
|
Choi, H. and Keller, R.H.: Co-existence of Chronic Lymphocytic
Leukemia and Hodgkin's Disease. Cancer 48:48-55, 1981.
|
|
Kaplan, H.J., Aeberg, T.M. and Keller, R.H.: Etiology of Recurrent
Clinical Uveitis. Ber Dtsch Ophthal Ges 78:159, 1981.
|
|
Kaplan, H.J. and Keller, R.H.: Recurrent Clinical Uveitis: Cell
Surface Markers on Vitreous Lymphocytes. Arch Ophthal 100:585-592,
1982 |
|
Keller, R.H., Fink, J.N., Lyman, S. and Pederson, G.: Suppressor
Cells in Asymptomatic Pigeon Breeders. J Clin Immunol 2:46-51, 1982.
|
|
Milson, T.J., Grief, D. and Keller, R.H.: The Variable Effect of
Cryopreservation on Peripheral Blood Mononuclear Populations. J Clin
Lab Immunol 7:205-218, 1982. |
|
Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Hypersensitivity
Pneumonitis In Non-human Primates. In Studies on the Relationship of
Immunoregulation and Disease Activity. J Immunol 128:116-123, 1982.
|
|
Keller, R.H.: Alpha-fetoprotein: Biologic and Clinical Potential. In
Tumor Imaging: The Radioimmunochemical Detection of Cancer.
Burchiel, S. and Rhodes, B. (eds) Mason Publishing, New York, pp.
179-188, 1982. |
|
Patrick, C.W. and Keller, R.H.: New Techniques in the Diagnosis of
Hematopoietic Malignancies: Monoclonal Antibodies, Flow Cytometry
and Cell Sorting. Am Soc Clin Pathol Sp Topic Series 20(3)106-109,
1982. |
|
Keller, R.H., Libnoch, J.A., Patrick, C.W., Blake, D.G., Choi, H.
and Hanson, R.D.: Fc Gamma Bearing T Cells in Non-Hodgkin's
Lymphomas. Diag Immunol 1:27-32, 1983. |
|
Keller, R.H., Feldman, E. and Libnoch, J.A.: Immunoregulatory
Abnormalities the Kindred of Waldenstrum's Macroglobulinemia
Patients. Am J Hematol 14:15-22, 1983. |
|
Keller, R.H. and Calvanico, N.J.: Suppressor Macro-molecules. Crit
Rev Immunol 5(2): 149-199, 1984. |
|
Fudenberg, H.H., Wilson, G.B., Keller, R.H., Metcalf, J.F., Pauling,
E.E., Stuart, E.J. and Floyd, E.: Clinical Application of the
Leukocyte Migration Inhibition Assay: New Methods for Determining
Transfer Factor Potency and for Prediction of Clinical Response. In
Proceedings of the IV International Conference on Transfer Factor.
Academic Press, New York, pp. 293-310, 1984. |
|
Patrick, C.W. and Keller, R.H.: A Simple Device for the Collection
of Cells Sorted by Flow Cytometry: Preservation of Integrity and
Viability. Cytometry 5(3):308-311, 1984. |
|
Keller, R.H., Milson, T.J., Janicek, K.M. and Patrick, C.W.:
Monoclonal Antibodies: Clinical Utility and the Misunderstood
Epitope. Lab Med 15(12):785-802, 1984. |
|
Keller, R.H., Swartz, S.J., Leven, S., Bar Sella, S. and Fink, J.N.:
Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and
Functional Studies of Bronchoalveolar Lavage Lymphocytes. Am Rev
Resp Dis 130:766- 771, 1984. |
|
Patrick, C.W., Swartz, S.J., Harrison, K.A. and Keller, R.H.:
Collection and Preparation of Hemopoietic Cells for Cell Marker
Analysis. Lab Med 15(10): 659-665, 1984. |
|
Patrick, C.W., Milson, T.J., McFadden, P.W. and Keller, R.H.: Flow
Cytometry and Cell Sorting. Lab Med 15(11):740-745, 1984.
|
|
Wilson, G.B., Fudenberg, H.H. and Keller, R.H.: Guidelines for
Immunotherapy of Antigen Specific Defects with Transfer Factor. J
Clin Lab Immunol 13:51-58, 1984. |
|
Baumann, M.A., Libnoch, J.A., Patrick, C.W., Choi, H. and Keller,
R.H.: Prolonged Survival in Richter's Syndrome with Subsequent
Re-emergence of Chronic Lymphocytic Leukemia: A Case Report
Including Serial Cell Surface Phenotype Analysis. Am J Hematol
20:67-72, 1985. |
|
Marti, G.E., Patrick, C.W., Muirhead, K., Magruder, L., Vail, M.,
Schuette, W., Keller, R.H., Horan, P.K. and Gralnick, H.R.: Normal
Blood Density Gradient Lymphocyte Subset Analysis: In an
Inter-Laboratory Flow Cytometric Comparison of 85 Normal Adults. Am
J Hematol 20:41-52, 1985. |
|
Milson, T.J., Patrick, C.W., Sohnle, P.G., Patrick, L.C. and Keller,
R.H.: Flow Cytochemical Analysis of Atopic Reactions. Diag Immunol
3:182-186, 1986. |
|
Milson, T.J., Patrick, C.W., Torke, N.J. and Keller, R.H.: Holding
Media for Cell Surface Phenotyping Analysis, J Immunol Methods 87:
155-159, 186. |
|
Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and
Keller, R.H.: Immunoregulatory Abnormalities in Myelodysplastic
Disorders. Am K Hematol 22:79-86, 1986 |
|
Hansen, R.M, Lerner, N., Abrams, R.A., Patrick, C.W., Malik, M.I.
and Keller, R.H.: Chronic Lymphocytic Leukemia with Pure Red Cell
Aplasia: Laboratory Demonstration of Persistent Leukemia in Spite of
Apparent Complete Clinical Remission. Am J Hematol 22:79-86, 1986.
|
|
Baumann, M.A., Keller, McFadden, P.W., Libnoch, J.A and Patrick,
C.W.: Myeloid Cell Surface Phenotype in Myelodysplasia: Evidence for
Abnormal Persistence of an Early Myeloid Differentiation Antigen. Am
J Hematol 23:22-26, 1986. |
|
Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and
Keller, R.H.: Correlation of Numbers of Natural Killer Cells with
Clinical Course in Large Cell Lymphoma. Cancer 57:2309-2312, 1986.
|
|
Patrick, C.W., Ash, R., Libnoch, J.A. and Keller, R.H.: Clinical
Cytometry and Immunophenotyping: I. Flow Cytometric Analysis of
Normal Peripheral Blood and Bone Marrow. Path Immunopathol Res
6:64-76, 1987. |
|
Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.:
Sequential Immunophenotypic Studies in Chronic Lymphocytic Leukemia:
UCLA Molecular Biology Symposium. Chronic Lymphocytic Leukemia:
Recent Progress-Future Directions. R. Gale and K. Rai (eds) Alan R.
Liss, New York, 59, 1987. |
|
Keller, R.H., Libnoch, J.A., Kallas, G.A., and Patrick, C.W.:
Sequential Evaluation of T Cell Subsets in B-CLL. UCLA Molecular
Biology Symposium Chronic Lymphocytic Leukemia: Recent
Progress-Future Directions. R. Galeand K. Rai (eds) Alan R. Liss,
New York, 59, 1987. |
|
Fudenberg, H.H, Whitten, H.D., Galbraith, G.M.P., Goust, J.M.,
Patrick, C.W. and Keller, R.H.: Deficiency of 'Interactive' T Cells
in Individuals with Recurrent Infection: Effect of DLE-TF Therapy.
Am J Med. In Press, 1994. |
|
Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M.,
Klimas, N.G. and Fletcher, M.A.: Association of Histocompatability
Class II Antigens with the Chronic Fatigue Immune Dysfunction
Syndrome. In Clin Inf Disease 1 8(Supp 1): S154-156, 1994.
|
|
|
Papers Submitted
In review and/or revision |
|
Patrick, C.W. and Keller, R.H.: A Comparative Study of
Anticoagulants in Cell Surface Maker Phenotyping and Functional
Analysis. Am J Clin Pathol. |
|
Keller, R.H., Choi, H., Libnoch, J.A. and Patrick, C.W.: A Natural
Murine Model of Non-Hodgkin's Lymphoma. J Immunol (in revision).
|
|
Choi, H., Libnoch, J.A., Aimargo, U., Heckman, M. and Keller, R.H.:
Castelman's Tumor: Well Differentiated Lymphocytic Lymphoma and
Large Cell Lymphoma in a Single Patient. Human Pathol (in revision).
|
|
Keller R.H., Wen K., and Kirchenbaum G. ALL-ergese a TCM blend of
standardized herbs for the treatment of allergies. (in revision)
|
|
Adult Growth Hormone Deficiency: A Correlate of Immune Overactivity
(in preparation) |
|
ABSTRACTS: Asterisks (*) denote those papers selected for
presentation at national or international meetings. |
| *
Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha-
fetoprotein in Human Lymphoproliferative Disease. Blood 46(4):1035,
1975. |
| *
Guebel, A.P., Keller, R.H., Summerskill, W.H.J., Tomasi, T.B. and
Shorter, R.G.: Cytotoxicity of Autologous and Normal Lymphocytes
Against Isolated Liver Cells in Patients with Primary Biliary
Cirrhosis. Gastroenterol 68:104, 1975. |
| *
Keller, R.H., Summerskill, W.H.J., Guebel, A.P., Shorter, R.G., and
Tomasi, T.B.: Alpha-fetoprotein and Suppression of Cell Mediated
Immunity in Chronic Acute Liver Disease (CALD). Gastroenterol
70:A-43:901, 1976. |
| *
Keller, R.H, Guirgis, H., Lynch, H. and Tomasi, T.B.:
Alpha-fetoprotein (AFP) in Cancer Prone Families. Clin Res 24:331,
1976. |
| *
Keller, R.H., Burritt, M.F., Thompson, R.L. and Tomasi, T.B.: Alpha-
fetoprotein (AFP): Synthesis in Allogeneic Reactions. Clin Res
24:447, 1976. |
| *
Keller, R.H., Burritt, M.F. and Tomasi, T.B.: Alpha-fetoprotein (AFP)
Synthesis in Allogeneic Reactions. Eleventh Leukocyte Culture
Conference, Tucson, AZ, September 1976. |
| *
Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde,
J., Lynch, J., Rankin, L., Maoney, K. and Harris, R.:
Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) in Cancer
Prone Families. In Proceedings of the Scientific Session of the
Third International Symposium on the Detection and Prevention, 1976.
|
| *
Vogten, A.J.M., Shorter, R.G., Summerskill, W.M.J., Keller, R.H. and
Tomasi, T.B.: Cell Mediated Cytotoxicity Against Human Liver
Lipoprotein in Liver Disease. Gastroenterol 71:A-41:934, 1976.
|
| *
Keller, R.H. and Tomasi, T.B.: AFP: A Potential Regulator of Immune
Function. Second International Conference on Disease of the Liver.
Bethesda, MA, March 1977. |
|
Keller, R.H., Blake, D.G., Lyman, S., Libnoch, J.A. and Fabiance,
M.: Suppressor Cells in Asymptomatic Chronic Lymphocytic Leukemia.
Clin Res 27:298, 1979. |
|
Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: Altered
Immunoregulation in Chronic Lymphocytic Leukemia. Blood 54:97A,
1979. |
|
Blake, D.G., Libnoch, J.A., Lyman, S. and Keller, R.H.: Altered
Immunologic Reactivity in Myelodysplastic Disorders. Blood, 54:97A,
1979. |
| *
Miller, P.P, Jordan, R.E. and Keller, R.H.: Suppression of Human
Lymphocyte Response by Circulating Immune Complexes. Clin Res 28:
351, 1980. |
| *
Keller, R.H., Fink, N.J., Lyman, S. and Pederson, G.: Altered
Immunoregulation in Hypersensitivity Pneumonitis. Clin Res 28:102,
1980. |
| *
Keller, R.H., Lyman, S. and Siebenlist, R.: The Influence of Human
Mononuclear Cell Histamine Production on T Cell Immunoregulation.
Clin Res 28:230, 1980. |
| *
Keller, R.H., Lyman, S. and Siebenlist, R.: Histamine in the Immune
Response. 4th World Congress of Immunology, Paris, France. July
1980. |
| *
Kaplan, H.J., Asberg, T.M. and Keller, R.H.: Lymphocyte Subset in
Clinical Uveitis. Abs Assoc Res Vision Opthal p. 33, 1980.
|
| *
Siebenlist, R., Calvanico, N.J., Stevens, J.O. and Keller, R.H.:
Immunoregulation in Hypersensitivity Pneumonitis. Fourth Midwest
Autumn Immunology Conference, Chicago, IL, 1980. |
| *
Lyman, S., Patrick, C.W. and Keller, R.H.: Non-Hodgkin's Lymphoma in
the Mouse: A Naturally Occurring Murine Model of NHL. Fourth Midwest
Autumn Immunology Conference, Chicago, IL, 1980. |
| *
Young, D.G., Hussey, C.V., Keller, R.H. and Pisciotta, A.V.:
Eradication of Acquired Factor VII Inhibitor in Hodgkin's Disease
Following Chemotherapy. Am Fed Clin Res 28(4):731, 1980.
|
| *
Keller, R.H., Patrick, C.W., Swartz, S.J., Libnoch, J.A. and Jordan,
R.E.: FlowCytometry as an Adjunct in the Diagnosis and Staging of
Lymphoproliferative Disease. IX International Conference on
Analytical Cytology. Schloss Elmau, Germany, 1980. |
| *
Wilson, R.J., Greiff, D. and Keller, R.H.: Cryopreservation of Non-
specific T Cell Suppressor Cells. Cryobiol 17:597, 1980.
|
| *
Pontzer, C. and Keller, R.H.: Rabbit Peripheral Blood T Cell
Separation. Fed Am Soc Exp Biol, 1980. |
| *
Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Immunoregulation in
Pigeon Breeders Disease. Clin Res 29:370, 1981. |
| *
Keller, R.H., Kirchner, P., Lyman, S., Siebenlist, R., Choi, H. and
Patrick, C.W.: Immunoregulatory T Cells in Non-Hodgkin's Lymphomas.
Blood 58:313, 1981. |
| *
Keller, R.H., Lyman, S., Choi, H. and Patrick, C.W.: A Natural Model
of Non-Hodgkin's Lymphoma. Blood 58:524, 1981. |
| *
Lauer, S., Casper, J., Keller, R.H., Kirchner, P. and Camitta, B.:
The Use of Counterflow Centrifugation-Elutriation for the Separation
of Bone Marrow Lymphoid Cells in Children with Acute Lymphocytic
Leukemia (ALL) and Metastatic Solid Tumors. Blood 58:133, 1981.
|
| *
Keller, R.H., Choi, H. and Patrick, C.W.: Nodular Non-Hodgkin's
Lymphoma in the Mouse. Blood 60:114A, 1982. |
| *
Keller, R.H., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood
Aneuploidy in Mycosis Fungoides and Pre-mycotic Lesions. Blood
60:146A, 1982. |
| *
Keller, R.H., Swartz, S.J., Lyons, M., Troy, J. and Jordan, R.E.:
Peripheral Blood Involvement in Skin-limited T Cell Malignancy. Am
Fed Clin Res 31:568, 1983. |
| *
Geoghegan, W.D., Jordan, R.E. and Keller, R.H.: Non-Langerhans Cells
in the Keratinocyte Band in Culture Expressing HLA-DR. Invest Derm
Am Fed Clin Res 31:568, 1983. |
| *
Keller, R.H., Swartz, S.J., Patrick, C.W. and Kaplan, H.J.:
Intraocular Lymphoma: A Possible Systemic Disease. Am Fed Clin Res
31:315, 1983. |
| *
Patrick, C.W., Libnoch, J.A., Choi, H. and Keller, R.H.: Flow
Cytometric Peripheral Blood Cell Surface Analysis as a Predictor of
Richter's Syndrome (RS) in Chronic Lymphocytic Leukemia. Blood
62:756, 1983. |
| *
Patrick, C.W., Swartz, S.J. and Keller, R.H.: A Comparative Study of
Heparin and Potassium EDTA as Anticoagulants for Cell Surface Marker
and Immunologic Functional Analysis. Am J Clin Pathol, 1983.
|
| *
Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke,
N.J.: Regression of Natural Murine Non-Hodgkin's Lymphoma Following
Immunotherapy with Immunoregulatory Cell Types. Blood 62:756, 1983.
|
| *
Keller, R.H., Wagner, D. and Patrick, C.W.: Sequential T Cell
Phenotypic and Functional Changes During a Comparative Study of
Rhinovirus Infection in Patients with the Acquired Immune Deficiency
Syndrome (AIDS). Blood 62:352, 1983. |
| *
Keller, R.H., Swartz, S.J. and Patrick, C.W.: Metachromatic Granules
in Human T8 (CD8) Bearing Lymphocytes. Fifth World Congress of
Immunology. Tokyo, Japan. July 1983. |
|
Libnoch, J.A., Patrick, C.W., Griffin, J. and Keller, R.H.: Flow
Cytometric Cell Surface Analysis as a Predictor of Leukemic
Transformation in the Myeo-dyplastic Syndrome (MDS). Blood 62:610A,
1983. |
| *
Calvanico, N.J., Pontzer, C. and Keller, R.H.: Regulation of Aerosol
Induced Pulmonary Inflammation in Rabbits. XII Congress of the
European Academy of Allergy and Clinical Immunology, Rome, Italy,
1983. |
| *
Patrick, C.W., Swartz, S.J., McFadden, P.W., Wallace, A. and Keller,
R.H.: A Comparative Study of Manual and Flow Cytometry Cell Surface
Marker Analysis. Soc Analytical Cytology, Sea Island, Georgia, 1983.
|
| *
Keller, R.H., Swartz, S.J., Troy, J., Patrick, C.W. and Jordan,
R.E.: Peripheral Blood Involvement in Skin Limited T Cell
Malignancy. Soc Analytical Cytology, Sea Island, Georgia, 1983.
|
| *
Keller, R.H., Swartz, S.J., Leven, S. and Bar Sella, S.:
Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and
Functional Studies of Bronchoalveolar Lavage Lymphocytes. Am Acd
Allergy 130:766-771, \ 1984. |
| *
Keller, R.H., Swartz, S.J., McFadden, P.W., Milson, T.J., Hermann,
J., Thomas, E. and Patrick, C.W.: Abnormal Peripheral Blood T Cell
DNA Content in Skin Limited T Cell Malignancy. Second International
Conference on Malignant Lymphoma, Lugano, Switzerland, June 1984.
|
| *
Patrick, C.W., Harrison, K.A, Libnoch, J.A., Cozine, M.G. and
Keller, R.H.: Monoclonal Antibody Profiles in Human B Cell
Lymphoproliferative Disorders Suggests that B4 Positive Lymphocytes
which Lack Expression of B1 Antigen May Include the B Memory Cells.
Second International Conference on Malignant Lymphoma, Lugano,
Switzerland, June 1984. |
| *
Patrick, C.W., McFadden, P.W., Buchholz, T.B., Milson, T.J.,
Libnoch, J.A. and Keller, R.H.: The Non-relevance of T4 to T8
(CD4:CD8) Ratios to Disease Activity in B Cell Malignancies. Second
International Conference on Malignant Lymphoma, Lugano, Switzerland,
June 1984. |
| *
Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke,
N.J.: Treatment of Naturally Occurring Murine Non-Hodgkin's
Lymphomas Using Immunoregulatory Cell Types and IL-2. Second
International Conference Malignant Lymphoma, Lugano, Switzerland,
June 1984. |
| *
Kissebah, A.H., James, R. Krakower, G., Arnaud, C., Etienne, J. and
Keller, R.H.: Holding Media for Cell Surface Phenotypic Analysis.
Midwest Autumn Conference, Chicago, IL, November 1984.
|
| *
Milson, T.J., Patrick, C.W., Torke, N.J., Janicek, K.M., Harrison,
K.A. and Keller, R.H.: Alterations in Lymphoid and Myeloid Cell
Surface Marker Phenotype Profiles Associated with the Development of
Basophilic Crisis in Chronic Granulocytic Leukemia (Ph + CGL). Blood
64(5):195A, 1984 |
| *
Patrick, C.W., Libnoch, J.A., Milson, T.J., Kortright, K.H. and
Keller, R.H.: Common Variant of B Cell Chronic Lymphocytic Leukemia
is Defined by the Monoclonal Antibody TQ1 (Leu 8). Blood 65(5):149,
1984. |
| *
Baumann, M.A., Patrick, C.W., Libnoch, J.A. and Keller, R.H.:
Myeloid and Lymphoid Cell Surface Phenotype in Myelodysplasia:
Correlation with In Vitro Assessment of Immune Function. Blood
64(5):186A, 1984. |
| *
Keller, R.H., Larrick, J.W., Swartz, S.J., Torke, N.J. and Patrick,
C.W.: Treatment of a Natural Model of Murine Non-Hodgkin's Lymphoma
with Recombination Interleukin 2(IL-2). Blood 64(5):181, 1984.
|
| *
Steven, G.C., Choi, H., Heckman, M.G. and Keller, R.H.: Comparison
of Flow Cytometry and In sit Cell Surface Marker Analysis. Midwest
Student Research Forum XVI, Wright State University, February 1985.
|
| *
Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J.
and Keller, R.H.: Regional Differences in Preadiopocyte Growth
Potential from Immature and Sexually Mature Female Rats. Am Fed Clin
Res 33:434, 1985. |
| *
Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J.
and Keller, R.H.: Regional Specialization of Subcutaneous Tissue
Growth Potential: Relationship to Ovarian Function. Am Diabetes
Assoc, Toronto, Canada, November 1985. |
| *
Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and
Keller, R.H.: Correlation of Natural Killer Cell Count with
Prognosis in Large Cell Lymphoma. Blood 66:185, 1985.
|
| *
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of
Dual Immunofluorescence Assay of Monoclonal Antibodies TQ1 and
(CD19) on Peripheral Blood Cells in Chronic Lymphocytic Leukemia.
Blood 66: 181, 1985. |
| *
Patrick, C.W., Libnoch, J.A., Baumann, M.A. and Keller, R.H.:
Alterations of Myeloid Surface Receptors recognized by the
Monoclonal Antibody MY 9 (CD33) in the Peripheral Blood May Serve to
Identify Those Myelodysplastic Patients at Increased Risk for
Leukemic Conversion. Blood 66:226, 1985. |
|
Keller, R.H., Milson, T.J., McFadden, P.W. and Patrick, C.W.: In
Vitro Augmentation of Immunologic Responsiveness in Patients with
AIDS and ARC Using Isoprinosine. Blood 66:113, 1985.
|
|
Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments
In \ Vitro Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia.
Blood 66:202, 1985. |
| *
Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments
In Vitro Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia
(B-CLL). International Symposium on Recent Approaches to Chronic
Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.
|
| *
Keller, R.H., Milson, T.J. and Patrick, C.W.: The Relationship of
Larger Lymphoid Elements, Clonally Restricted DNA Cell Cycle
Analysis and Rai Staging in Chronic Lymphocytic Leukemia (B-CLL).
International Symposium on Recent Approaches to Chronic
Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.
|
| *
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Immunophenotypic
Dissection Of Chronic Lymphocytic Leukemia. International Symposium
on Recent Approaches to Chronic Lymphoproliferative Disease, Prague,
Czechoslovakia, September 1985. |
| *
Keller, R.H., Libnoch, J.A., Patrick, L.C. and Patrick, C.W.: In
Vitro Improvement of Cellular and Humoral Immune Response by
Isoprinosine in B-CLL. XXI Congress of the International Society of
Haematology, Sydney, Australia, May 1986. |
| *
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Prolymphocytic
Leukemia of B Cells is a Distinct Biologic Stage in B Cell
Maturation. XXI Congress of The International Society of Haematology,
Sydney, Australia, May 1986. |
| *
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Sequential Changes in
the Expression of Lymphoid Surface Membrane Receptors in Chronic B
Cell Lymphoproliferative Disease. XXI Congress of the International
Society of Haematology, Sydney, Australia, May 1986.
|
| *
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of
Dual Immunofluorescence Assay of Monoclonal Antibodies TQ1 and B4
(CD19) on Circulating B Cells in Chronic Lymphocytic Leukemia
(B-CLL). Sixth International Congress of Immunology, Toronto,
Canada, July 1986. |
| *
Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.:
Sequential Clinical, Immunoregulatory, Phenotypic and Functional
Changes in Patients with AIDS and ARC treated with Isoprinosine. XXI
Congress of the International Society of Haematology, Sydney,
Australia, May 1986. |
| *
Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.:
Sequential Clinical, Immunoregulatory, Phenotypic and Functional
Changes in Patients with AIDS and ARC treated with Isoprinosine.
International Conference on the Acquired Immunodeficiency Syndrome,
Paris, France, June 1986. |
| *
Keller, R.H., Libnoch, J.A. and Patrick, C.W.: T Cell Alterations in
B-CLL: Sequential Changes in CD4 and CD8 Bearing Cells and in T Cell
Immunoregulation. UCLA Symposium on Molecular and Cell Biology,
Silverado, California, December 1986. |
| *
Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.:
Sequential Immunophenotypic Studies in Chronic Lymphocytic Leukemia.
UCLA Symposium on Molecular and Cell Biology, Silverado, California,
December 1986. |
| *
Reiter, W.M., Berger, D.S., Vorce, S., Cimoch, P.J., Vargas, A. and
Keller, R.H.: Combination Zidovudine and Didanosine Therapy for
Patients Remaining Persistently HIV P24 Antigen-Positive Despite
Zidovudine Monotherapy. VIII International AIDS Conference,
Amsterdam, Netherlands, 1992. |
| *
Reiter, W.M., Keller, R.H., Cimoch, P.J. and Forgione, A.: A Rapid
Quantitative Flow Cytometry Assay to Evaluate CD4 + - Lymphocyte
Activation Potential in Patients with HIV-1 Infection. VIII
International AIDS Conference, Amsterdam, Netherlands, 1992.
|
| *
Cimoch, P.J., Reiter, W.M., Vorce, D., Cassarella, S.K., Thompson,
B. and Keller, R.H.: The Occurrence of Cytomegalovirus (CMV) Viruria
in Late- Stage HIV-1 Infection and its Association with CMV Organ
Involvement. VIII International AIDS Conference, Amsterdam,
Netherlands, 1992. |
| *
Reiter, W.M., Beach, R.S., Vorce, D., Cimoch, P.J., Vargas, A.,
Thompson, B. and Keller, R.H.: Longitudinal Analysis the Effect of
Anti-retroviral Monotherapy on CD4+ Lymphocyte Percentage. VIII
International AIDS Conference, Amsterdam, Netherlands, 1992.
|
| *
Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M.,
Klimas, N.G. and Fletcher, M.A.: Correlation of DR4 and DQ1 with
Immunologic Defects in the Chronic Fatigue Syndrome. First
International Chronic Fatigue Syndrome Research Conference, Albany,
New York, October 1992. |
| *
Keller, R.H., Reiter, W.M., Lane, J.T., Klimas, N.G., Vargas, A. and
Maislis, J.A.: Treatment of Late-Stage AIDS Patients with Combined
Monthly Anti-HIV Hyperimmunoglobulins and Haplotype-matched
Peripheral Blood Lymphocytes. XI International Conference on AIDS,
Berlin, 1993. |
|
Reiter, W.M., Cimoch, P.J., Vorce, D.E., Keller, R.H., Berger, D.
and Ping, A.:Eighteen Month Longitudinal Analysis of the Effect of
Zidovine MonotherapyCompared to Combination Antiretroviral Therapy
on HIV1 Disease Progression. IX International Conference on AIDS,
Berlin 1993. |
| *
Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H., Berger, D.S.,
and Ping, A.C.: Cytotoxic CD8+ Lymphocyte Response to HIV-1
Infection Correlated with Longitudinal Analysis of CD4+ Lymphocyte
Percentage. IX International Conference on AIDS, Berlin, 1993
|
|
Berger, D.S., Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H.
and Ping, A.C.: Prevalence of Red Blood Cell Magnesium Deficiency in
HIV-1 Infected Patients and its Association with Fatigue and
Myalgia. IX International Conference on AIDS, Berlin, 1993.
|
|
Reiter, W.M., Tomaka, F., Keller, R.H., Cimoch, P.J., Vargas, A. and
Vorce, D.E.: Unrecognized Moderate to Advanced Immunodeficiency in
"HIV-Aware" Asymptomatic, Untreated Person with HIV-1 Infection. IX
International Conference on AIDS, Berlin, 1993. |
| *
Gomatos, P.J., Keller, R.H., Reiter, W.M., Lane, J.T., Cimoch, P.J.,
Vorce, D.E., Gianetti, B.L. and Uribe, M.R.: Haplotype-Matched
Peripheral Blood Mononuclear Cell (PBMC) Transfusions in Patients
with Late-Stage AIDS. X International Conference on AIDS, Yokohama,
Japan, 1994. |
| *
Cimoch, P.J., Loss, S.D., Houghton, R.A., Reiter, W.M., Keller, R.H.,
Vorce, D.E., Nemecheck, P.M., Berger, D.S. and Tomaka, F.L.:
Antibody Response to Pneumococcal Vaccination in HIV-1 Infected
Patients. X International Conference on AIDS, Yokohama, Japan, 1994.
|
| *
Tomaka, F.L., Cimoch, P.J., Reiter, W.M., Keller, R.H., Berger,
D.S., Piperato, J.R., Nemecheck, P.M., Loss, S.D. and Houghton,
R.A.: Prevalence of Nutritional Deficiencies in Patients with HIV-1
Infection. X International Conference on AIDS, Yokohama, Japan,
1994. |
| *
Keller, R.H., Helder, L.M., Piperato, J.P., Klimas, N.G., Reiter,
W.M., Fletcher, M.A., Vorce, D.E. and Pittibone, H.: Symptomatic
Improvement Associated with Down Regulation of Immune Hyper
Reactivity by Calcium Channel Blockade in CFIDs. American
Association for Chronic Fatigue Syndrome Research Conference, Ft
Lauderdale, Florida, 1994. |
| *
Keller, R.H., Nolan, R.P. and Patrick, L.C.: Natural Human
Interferon ( (Alpha Leukoferon) Therapy in a Cohort of Hemophiliacs
Co-infected with . HIV and Hepatitis C. Fourth Conference on
Retroviruses and Opportunistic Infections,Washington, DC, 1997.
|
| *
Patrick, C.W. and Keller, R.H.: Patient Screening for Myelodysplasia
in Long- Term HIV+ Individuals. Conference on Clinical Laboratory
Testing in HIV, Atlanta, GA, 1998. |
| *
Patrick, C.W., DeLeon, M., A. Leon, and Keller, R.H.: Measurement of
glutathione (GSH) as Indicator of Immune Status. Conference on
Clinical Laboratory Testing in HIV, Atlanta, GA 1998.
|
|
** Kushch, A. and Keller, R.H.: Neuropsychological Correlates of
Adjunct Therapy with a Nutritional/Vitamin Supplement in a Medical
Patient Sample. National Academy of Neuropsychology, ** Orlando, FL,
November 2000. |
|
Keller, R.H.:PBS 119 Abstract "Clinical Results of PBS 119 in Eight
Patients for Two Years" Submitted to the 12th Conference on
Retroviruses & Opportunistic Infections (CROI), 2005
|
|
Keller, R.H.: PBS 119 Abstract "In Vitro Analysis of PBS 119 Against
HIV Viral Activity in Lab Adapted and HAART Resistant Strains of
HIV" Submitted to the 12th Conference on Retroviruses &
Opportunistic Infections (CROI), 2005 |
| *
Keller, R.H, Miller D glutathione and DHA deficiency in HIV/AIDS :
Correction with Immune Vitality 16th International AIDS congress
Toronto Canada 8/2006 |
| *
Keller, R.H And Nyugen V. : PBS 119 A Novel Host - Viral Interaction
inhibitor 16th International AIDS Congress Toronto Canada 8/2006
|
|
|
|
Disclaimer:
For the diagnosis or treatment of any disease please consult a
licensed physician.
EVERY
OBJECT IN THIS UNIVERSE VIBRATES AT IT'S OWN FREQUENCY
NOW THERE'S A
WAY TO TUNE INTO YOURS AND RESET IT FOR OPTIMUM
WELLNESS!
|
|
|
|
